Comments
Caplin Point Laboratories has informed the exchanges that officials of European Union GMP had recently carried out inspection of the company’s sterile injectable facility (Unit IV). The outcome of the inspection is very positive and it is likely that approval may be accorded shortly, the company said in the notification. Shares of Caplin Point Laboratories on the NSE closed at ₹884.95, down 0.7 per cent over the previous day’s close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.